跳至主要内容
临床试验/NCT04450017
NCT04450017已完成不适用

Clinical Features of Severe Patients With COVID-19

Federal Research Clinical Center of Federal Medical & Biological Agency, Russia1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年4月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
Mechanical ventilation duration

研究概览

简要总结

As coronavirus disease 2019 (COVID-19) spreads across the world, the intensive care unit (ICU) community must prepare for the challenges associated with this pandemic. Providing an efficient care to the patients of the most severely affected category - intensive care unit (ICU) patients - has become one of the serious problems appearing in the COVID-19 pandemics. A typical patient's clinical portrait in ICU of COVID centers is very similar in different countries, however, the key to improve the treatment results for critically ill patients has not yet been found. Data on predictors of severe course in COVID-19 is limited. Knowledge of predictors of severe course of disease can lead to different selection of therapeutic strategy, determine the group of risk of patients for severe course of disease, and improve outcomes.

详细描述

The clinical disease (COVID-19) results in critical illness in about 5% of patients. The aim of the study is to identify predictors of the severe pneumonia caused by the SARS-CoV-2 virus, and to describe the clinical features of patients admitted to an ICU of the COVID-center of the Federal Research Clinical Center of Federal Medical & Biological Agency on the first day and in dynamics till discharge from the ICU or death.

The demographic and clinical data will be collected. Laboratory data (hemoglobin, lymphocytes, neutrophil to lymphocyte ratio, D-dimer level, IL-6, procalcitonin, glucose level, high-sensitive troponin Т, vitamin D level, signs of the presence of a secondary bacterial infection, immunogram and Instrumental data (CT-scan, Electrocardiography, echocardiography, arterial and venous ultrasound investigation) will be analysed.

This study is singlecentral observational trial.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • all patients with COVID-19 admitted to the ICU with invasive and noninvasive ventilation

排除标准

  • less than 24 hours in ICU by any reason,
  • chronic decompensated diseases with extrapulmonary organ dysfunction (tumour progression, liver cirrhosis, congestive heart failure),
  • atonic coma.

结局指标

主要结局

Mechanical ventilation duration

时间窗: 30 days

The amount of mechanical ventilation days

Non-invasive Mechanical ventilation duration

时间窗: 30 days

The amount of Non-invasive mechanical ventilation days

Mortality

时间窗: 60 days

The dead and survived patients ratio

次要结局

  • Сomplete blood count dynamics(Change from baseline on day 15 during ICU treatment)
  • Biochemistry analysis(Change from baseline on day 5 during ICU treatment)
  • Vitamin D level dynamics(Change from baseline on day 15 during ICU treatment)
  • Immunogram dynamics(Change from baseline on day 15 during ICU treatment)
  • Сomplete blood count(Change from baseline on day 5 during ICU treatment)
  • Computer tomography(Change from baseline on day 5 during ICU treatment)
  • High-sensitive troponin Т(Change from baseline on day 5 during ICU treatment)
  • Immunogram(Change from baseline on day 5 during ICU treatment)
  • Biochemistry analysis dynamics(Change from baseline on day 15 during ICU treatment)
  • Vitamin D level(Change from baseline on day 5 during ICU treatment)
  • High-sensitive troponin Т dynamics(Change from baseline on day 15 during ICU treatment)

研究者

发起方
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验